LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs

​LG AI Research and D&D Pharmatech have entered into an agreement to collaborate on the development of next-generation oral peptide drugs, the companies announced following a signing ceremony held at the LG Twin Towers in Yeouido, Seoul.

The post LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

AngioDynamics secures FDA approval for RELIEF study of NanoKnife
First patient dosed in Deciphera’s Phase III INTREPID study
Alpha Cognition begins enrolment in RESOLVE Phase IV trial for Zunveyl
Altaris to acquire Simulations Plus in $375m all-cash deal
Distalmotion secures second FDA gynaecology clearance for DEXTER system

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us